MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers18132117

Медицинская библиотека · Cancers · 2026

Clinical Impact of Total Neoadjuvant Therapy Combined with Dose-Escalated Intensity-Modulated Radiotherapy for Lower Rectal Cancer: A Comparison with Conventional Neoadjuvant Chemoradiotherapy.

Kawamura Mikio, Toyomasu Yutaka, Yamashita Shinji, Ieki Hideharu, Imaoka Hiroki, Shimura Tadanobu, Kitajima Takahito, Okugawa Yoshinaga, Okita Yoshiki, Ohi Masaki, Nomoto Yoshihito, Toiyama Yuji

СтатьяПеревод пока не подготовлен

Аннотация

Background

This study aimed to compare the outcomes and safety profiles of total neoadjuvant therapy (TNT) combined with dose-escalated intensity-modulated radiotherapy (IMRT) and conventional neoadjuvant chemoradiotherapy (NACRT) using three-dimensional conformal radiotherapy (3D-CRT) for locally advanced lower rectal cancer.

Methods

This single-institution retrospective study included 51 patients treated with TNT using IMRT from 2018 to 2023 and 53 patients treated with conventional NACRT from 2001 to 2018. TNT consisted of IMRT at a total dose of 54 Gy with capecitabine, whereas NACRT consisted of 3D-CRT at a total dose of 45 Gy with a 5-fluorouracil-based regimen. Survival outcomes, treatment compliance, adverse events, surgical complications, and combined complete response (CR), defined as clinical CR plus pathological CR, were evaluated.

Results

The combined CR rate was significantly higher in the TNT with IMRT group than in the NACRT group (43.1% vs. 5.7%). Overall survival and local recurrence-free survival did not differ significantly between the groups, whereas recurrence-free survival was significantly better in the TNT with IMRT group. Treatment compliance was comparable between the groups. Grade ≥ 3 adverse events during radiotherapy were less frequent in the TNT with IMRT group than in the NACRT group (7.8% vs. 22%), and major surgical complications did not differ significantly.

Conclusions

TNT combined with dose-escalated IMRT was associated with a higher combined CR rate, favorable disease-free survival, and acceptable toxicity in this cohort. However, given the retrospective historical control design, chronological differences, follow-up imbalance, and potential residual confounding, these findings should be interpreted cautiously and require validation in prospective studies with longer follow-up.

Для цитирования: Kawamura Mikio, Toyomasu Yutaka, Yamashita Shinji, Ieki Hideharu, Imaoka Hiroki, Shimura Tadanobu, Kitajima Takahito, Okugawa Yoshinaga, Okita Yoshiki, Ohi Masaki, Nomoto Yoshihito, Toiyama Yuji. Clinical Impact of Total Neoadjuvant Therapy Combined with Dose-Escalated Intensity-Modulated Radiotherapy for Lower Rectal Cancer: A Comparison with Conventional Neoadjuvant Chemoradiotherapy.. Cancers. 2026. DOI: 10.3390/cancers18132117.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.